BRCA1/2 Mutations in Slovenian Breast Cancer Families
Author Information
Author(s): Krajc Mateja, Teugels Erik, Zgajnar Janez, Goelen Guido, Besic Nikola, Novakovic Srdjan, Hocevar Marko, De Grève Jacques
Primary Institution: Institute of Oncology Ljubljana
Hypothesis
What is the mutation spectrum of BRCA1/2 in Slovenian breast/ovarian cancer families?
Conclusion
The study found a high mutation detection rate and identified a limited array of recurring mutations in Slovenian families.
Supporting Evidence
- A BRCA1/2 mutation was found in 56 out of 145 families tested.
- Five highly recurrent specific mutations were identified in the study.
- The IVS16-2A>G mutation in BRCA2 appears to be a unique founder mutation in the Slovenian population.
- The study observed a high participation rate in genetic testing among probands.
Takeaway
This study looked at families in Slovenia to see if they had certain gene changes that could lead to breast cancer, and they found that many families had these changes.
Methodology
The study analyzed leucocyte DNA from blood samples of cancer patients using various genetic testing methods.
Limitations
The sample size and mixed inclusion criteria limit the ability to assess genotype-phenotype correlations accurately.
Participant Demographics
Families residing in Slovenia with a history of breast and/or ovarian cancer.
Statistical Information
P-Value
0.038
Statistical Significance
p = 0.038
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website